Has Meaghan Phipps, MD received payments from drug or device companies?

Yes. Drug and device makers reported $3,715 in general payments to Meaghan Phipps, MD across 57 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Meaghan Phipps, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Meaghan Phipps, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Meaghan Phipps, MD

Transplant Hepatology · New York, NYNPI 1861887184

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,372 of the $3,715 with a category attached, or 63.9%. 13 manufacturers reported payments, led by AstraZeneca at 39.4% of the total. 2025 is the largest year on record at $2,329, more than ten times the $82 reported in 2019.

$3,715in general payments, 2019–2025

Across 57 payments — averaging $65.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$1K
Trisalus Life Sciences, Inc.$647
Gilead$538
Madrigal Pharmaceuticals$386
Fujifilm Healthcare Americas Corporation$208
Ipsen Biopharmaceuticals, Inc$100
plus $371 from 7 others

What the payments were for

Consulting fees$1,34336%
Food & beverage$2,37264%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca	2	$1,464
Trisalus Life Sciences, Inc.	3	$647
Gilead	19	$538
Madrigal Pharmaceuticals	15	$386
Fujifilm Healthcare Americas Corporation	2	$208
Ipsen Biopharmaceuticals, Inc	3	$100
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	3	$99
Mallinckrodt Hospital Products Inc.	4	$91
Davol Inc.	1	$67
Mirum Pharmaceuticals, Inc.	2	$37
Amgen	1	$33
AbbVie	1	$23
Intra-sana Laboratories	1	$22

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,715 in reported general payments places this provider in the 55th percentile of 36 transplant hepatology providers in New York.

See all transplant hepatology providers in New York →

Medicare billing

Part B allowed, 2024

$46,015

Medicare patients

Services billed

349

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
ErtapenemErtapenem Sodium	11	$4,543
Mycophenolate Mofetil	16	$2,952
Carvedilol	14	$127

Paid to pharmacies, not to this prescriber.

Other transplant hepatology in New York

Nikolaos PyrsopoulosNew York$251K
James ParkNew York$81K
Amon AsgharpourNew York$58K
Giuseppe CullaroNew York$50K
Julia WattacherilNew York$37K
Gene ImNew York$15K
Elizabeth VernaNew York$11K
Rajani SharmaNew York$11K
Annmarie LiapakisNew York$10K
Alyson FoxNew York$10K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →